[HTML][HTML] Mesoporous silica nanoparticles for therapeutic/diagnostic applications
Based on unique intrinsic properties of mesoporous silica nanoparticles (MSNs) such as
high surface area, large pore size, good biocompatibility and biodegradability, stable …
high surface area, large pore size, good biocompatibility and biodegradability, stable …
Recent advances of cocktail chemotherapy by combination drug delivery systems
Combination chemotherapy is widely exploited for enhanced cancer treatment in the clinic.
However, the traditional cocktail administration of combination regimens often suffers from …
However, the traditional cocktail administration of combination regimens often suffers from …
Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects
S Barua, S Mitragotri - Nano today, 2014 - Elsevier
Nanoparticles (NPs) have emerged as an effective modality for the treatment of various
diseases including cancer, cardiovascular and inflammatory diseases. Various forms of NPs …
diseases including cancer, cardiovascular and inflammatory diseases. Various forms of NPs …
Enzyme-responsive nanomaterials for controlled drug delivery
Enzymes underpin physiological function and exhibit dysregulation in many disease-
associated microenvironments and aberrant cell processes. Exploiting altered enzyme …
associated microenvironments and aberrant cell processes. Exploiting altered enzyme …
Nanoparticle–hydrogel superstructures for biomedical applications
The incorporation of nanoparticles into hydrogels yields novel superstructures that have
become increasingly popular in biomedical research. Each component of these nanoparticle …
become increasingly popular in biomedical research. Each component of these nanoparticle …
Microfluidic-assisted fabrication of carriers for controlled drug delivery
The microfluidic technique has brought unique opportunities toward the full control over the
production processes for drug delivery carriers, owing to the miniaturisation of the fluidic …
production processes for drug delivery carriers, owing to the miniaturisation of the fluidic …
Tailoring porous silicon for biomedical applications: from drug delivery to cancer immunotherapy
In the past two decades, porous silicon (PSi) has attracted increasing attention for its
potential biomedical applications. With its controllable geometry, tunable nanoporous …
potential biomedical applications. With its controllable geometry, tunable nanoporous …
Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
Glioblastoma multiforme (GBM) is one of the worst brain tumors arising from glial cells,
causing many deaths annually. Surgery, chemotherapy, radiotherapy and immunotherapy …
causing many deaths annually. Surgery, chemotherapy, radiotherapy and immunotherapy …
Silicon-containing nanomedicine and biomaterials: materials chemistry, multi-dimensional design, and biomedical application
L Chen, S Zhang, Y Duan, X Song, M Chang… - Chemical Society …, 2024 - pubs.rsc.org
The invention of silica-based bioactive glass in the late 1960s has sparked significant
interest in exploring a wide range of silicon-containing biomaterials from the macroscale to …
interest in exploring a wide range of silicon-containing biomaterials from the macroscale to …
Nanoformulations for combination or cascade anticancer therapy
Nanoparticle drug formulations have been extensively investigated, developed, and in some
cases, approved by the Food and Drug Administration (FDA). Synergistic combinations of …
cases, approved by the Food and Drug Administration (FDA). Synergistic combinations of …